Immunotherapy Against Lung Cancer
portes grátis
Immunotherapy Against Lung Cancer
Emerging Opportunities and Challenges
Eri, Rajaraman Eri; Andreoli Pinto, Terezinha de Jesus; Dua, Kamal; Goh, Bey-Hing; Paudel, Keshav Raj; Bhatt, Shvetank
Springer Verlag, Singapore
03/2024
389
Dura
Inglês
9789819971404
15 a 20 dias
Descrição não disponível.
Chapter 1_An introduction to Lung cancer.- Chapter 2_Immunobiology of Lung cancer.- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy.- Chapter 4_Recent advances in the immunotherapy of Lung cancer.- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer.- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer.- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer.- Chapter 9_IDO and TGF-? inhibitors for the treatment of Lung cancer.- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer.- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer.- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer.- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy.- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer.- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer.- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer.- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
PD-1 inhibitors;Lung cancer;Adoptive Cell Therapy;Immunotherapy;Vaccines
Chapter 1_An introduction to Lung cancer.- Chapter 2_Immunobiology of Lung cancer.- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy.- Chapter 4_Recent advances in the immunotherapy of Lung cancer.- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer.- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer.- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer.- Chapter 9_IDO and TGF-? inhibitors for the treatment of Lung cancer.- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer.- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer.- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer.- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy.- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer.- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer.- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer.- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer.- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
